Home › Calculator › SVRA Dividend Calculator 2026
SVRA Dividend DRIP Calculator 2026
37.24% YieldHealthcareSavara Inc. · NASDAQ
Price: $5.37 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When SVRA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your SVRA snowball 📈
$10,000 in SVRA → $129563105.77M in 10 years · $10,768,689,220,921.54/month
About Savara Inc. (SVRA) — Dividend Analysis 2026
Savara Inc. is a biopharmaceutical firm in the clinical development phase, specializing in therapies for uncommon respiratory conditions. Their primary investigational drug, molgramostim, is an inhaled form of granulocyte-macrophage colony-stimulating factor (GM-CSF). This compound is currently undergoing Phase III trials to address autoimmune pulmonary alveolar proteinosis. The company's main operations are situated in Austin, Texas.
Compare SVRA with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full SVRA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SVRA position with:
🌍 SVRA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold SVRA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 37.24% | 34.44% | $3,724 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 31.65% | 28.85% | $3,165 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 29.79% | 26.99% | $2,979 / yr |
| 🇬🇧 UK ISA | 0% | 37.24% | 34.44% | $3,724 / yr |
| 🇬🇧 UK Taxable | 8.75% | 33.98% | 31.18% | $3,398 / yr |
| 🇨🇦 TFSA | 0% | 37.24% | 34.44% | $3,724 / yr |
| 🇨🇦 CA Taxable | 25% | 27.93% | 25.13% | $2,793 / yr |
| 🇦🇺 Super (pension) | 15% | 31.65% | 28.85% | $3,165 / yr |
| 🇦🇺 AU Taxable | 30% | 26.07% | 23.27% | $2,607 / yr |
| 🇩🇪 DE Taxable | 26.375% | 27.42% | 24.62% | $2,742 / yr |
| 🇫🇷 FR Taxable | 30% | 26.07% | 23.27% | $2,607 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 SVRA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 SVRA Dividend Payment Schedule
SVRA pays quarterly — 4 times per year. Next ex-div: TBD.
📊 SVRA vs Healthcare Benchmarks
How SVRA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SVRA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ SVRA Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SVRA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Savara Inc. (SVRA) is currently trading at $5.37, 11% below its 52-week high. The current dividend yield is 37.24% based on an annual payout of $2.00 per share.
SVRA (Savara Inc.) — 37.24% Dividend Yield Analysis
Savara Inc. (SVRA) is a healthcare stock currently trading at $5.37 with a dividend yield of 37.24%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (37.24%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.